Anthocyanins in Vascular Health and Disease : Mechanisms of Action and Therapeutic Potential
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Related Research Unit(s)
Detail(s)
Original language | English |
---|---|
Pages (from-to) | 289-302 |
Journal / Publication | Journal of Cardiovascular Pharmacology |
Volume | 84 |
Issue number | 3 |
Publication status | Published - Sept 2024 |
Link(s)
Abstract
ABSTRACT: Unhealthy lifestyles have placed a significant burden on individuals' cardiovascular health. Anthocyanins are water-soluble flavonoid pigments found in a wide array of common foods and fruits. Anthocyanins have the potential to contribute to the prevention and treatment of cardiovascular disease by improving lipid profiles and vascular function, reducing blood glucose levels and blood pressure, and inhibiting inflammation. These actions have been demonstrated in numerous clinical and preclinical studies. At the cellular and molecular level, anthocyanins and their metabolites could protect endothelial cells from senescence, apoptosis, and inflammation by activating the phosphoinositide 3-kinase/protein kinase B/endothelial nitric oxide synthases, silent information regulator 1 (SIRT1), or nuclear factor erythroid2-related factor 2 pathways and inhibiting the nuclear factor kappa B, Bax, or P38 mitogen-activated protein kinase pathways. Furthermore, anthocyanins prevent vascular smooth muscle cell from platelet-derived growth factor -induced or tumor necrosis factor-α-induced proliferation and migration by inhibiting the focal adhesion kinase and extracellular regulated protein kinases signaling pathways. Anthocyanins could also attenuate vascular inflammation by reducing the formation of oxidized lipids, preventing leukocyte adhesion and infiltration of the vessel wall, and macrophage phagocytosis of deposited lipids through reducing the expression of cluster of differentiation 36 and increasing the expression of ATP-binding cassette subfamily A member 1 and ATP-binding cassette subfamily G member 1. At the same time, anthocyanins could lower the risk of thrombosis by inhibiting platelet activation and aggregation through down-regulating P-selectin, transforming growth factor-1, and CD40L. Thus, the development of anthocyanin-based supplements or derivative drugs could provide new therapeutic approaches to the prevention and treatment of vascular diseases. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Research Area(s)
Citation Format(s)
Anthocyanins in Vascular Health and Disease: Mechanisms of Action and Therapeutic Potential. / Zhao, Yaping; Wang, Li; Huang, Yu et al.
In: Journal of Cardiovascular Pharmacology, Vol. 84, No. 3, 09.2024, p. 289-302.
In: Journal of Cardiovascular Pharmacology, Vol. 84, No. 3, 09.2024, p. 289-302.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review